Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.
Merck's pharmaceutical business, which develops a wide range of drugs for different disease areas, booked $13.46 billion in revenue during the quarter. That's up 6% from the same period a year ago., the pharmaceutical division revenue grew 14%.
reported for the second quarter of 2022. Analysts had been expecting the drug to rake in $187.6 million in sales, according to FactSet estimates.Pfizer The pharmaceutical division's growth was largely fueled by the popular antibody treatment Keytruda, which is used to treat several types of cancer.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Charles Hoskinson Explains Why He Does Not Have Public Cardano Wallet.IOHK_Charles, the founder of Cardano, defends his decision not to have a public wallet
Read more »
John Walsh Talks Conan The Barbarian Making Of Book & Shares Exclusive ImagesAuthor John Walsh (walshbros) chats with Screen Rant about his new book, ConantheBarbarian: The Official Story of the Film, and shares exclusive behind-the-scenes production images from the Arnold Schwarzenegger movie:
Read more »
Michelle Yeoh shares behind-the-scenes pics from her wedding following 19-year engagementCongratulations, Michelle Yeoh and Jean Todt!
Read more »
Asia shares extend gains; wary eye on Japan yieldsThe week will include central-bank meetings and earnings updates from Amazon and Apple.
Read more »
Ethereum's 8th birthday: Crypto industry shares its top momentsOn this day eight years ago, the ethereum Foundation announced that the Ethereum network has rolled out live. Since then, Ethereum has grown to be one of the most integral elements of the crypto industry.
Read more »